The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial) - Trial NCT06321575
Access comprehensive clinical trial information for NCT06321575 through Pure Global AI's free database. This phase not specified trial is sponsored by Avantec Vascular and is currently Recruiting. The study focuses on Peripheral Arterial Disease. Target enrollment is 159 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Golazo® Peripheral Atherectomy System (Golazo® Peripheral AS)
Interventional
device
Sponsor & Location
Avantec Vascular
Timeline & Enrollment
N/A
Apr 25, 2024
Nov 01, 2026
Primary Outcome
Freedom from major adverse events (MAE),Technical success
Summary
The objective of this study is to establish reasonable assurance of safety and effectiveness
 of the Golazo® Peripheral Atherectomy System when used as indicated in 159 subjects with
 symptomatic infrainguinal peripheral arterial disease (PAD) in up to 15 investigational sites
 in the U.S.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06321575
Device Trial